Gene Therapy

Hemophilia Therapeutics Development Regulatory Approval FDA Approval

FDA Official Peter Marks Resigns Over Vaccine Policy Disputes

Marks' resignation, effective April 5, follows clashes with HHS Secretary Robert F. Kennedy Jr. over vaccine misinformation and public health priorities.

5 ARTICLES

4mo ago

Pfizer Ends Hemophilia Gene Therapy Partnership With Sangamo, Sending Stock Plummeting